Not logged in Prognostic pan-cancer and single-cancer models: A large-scale analysis using a real-world clinico-genomic database McGough, Sarah F.; Lyalina, Svetlana; Incerti, Devin; Huang, Yunru; Tyanova, Stefka; Mace, Kieran; Harbron, Chris; Copping, Ryan; Narasimhan, Balasubramanian; Tibshirani, Robert Share Save
Share Save
Share Save
Learning from data with structured missingness Mitra, Robin; McGough, Sarah F.; Chakraborti, Tapabrata; Holmes, Chris; Copping, Ryan; Hagenbuch, Niels; Biedermann, Stefanie; Noonan, Jack; Lehmann, Brieuc; Shenvi, Aditi; Doan, Xuan Vinh; Leslie, David; Bianconi, Ginestra; Sanchez-Garcia, Ruben; Davies, Alisha; Mackintosh, Maxine; Andrinopoulou, Eleni-Rosalina; Basiri, Anahid; Harbron, Chris; MacArthur, Ben D. Share Save
Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data Liu, Ruishan; Rizzo, Shemra; Waliany, Sarah; Garmhausen, Marius Rene; Pal, Navdeep; Huang, Zhi; Chaudhary, Nayan; Wang, Lisa; Harbron, Chris; Neal, Joel; Copping, Ryan; Zou, James Share Save
Machine Learning Prediction of Clinical Trial Operational Efficiency Wu, Kevin; Wu, Eric; DAndrea, Michael; Chitale, Nandini; Lim, Melody; Dabrowski, Marek; Kantor, Klaudia; Rangi, Hanoor; Liu, Ruishan; Garmhausen, Marius; Pal, Navdeep; Harbron, Chris; Rizzo, Shemra; Copping, Ryan; Zou, James Share Save
MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial Pott, Christiane; Sehn, Laurie H.; Belada, David; Gribben, John; Hoster, Eva; Kahl, Brad; Kehden, Britta; Nicolas-Virelizier, Emmanuelle; Spielewoy, Nathalie; Fingerle-Rowson, Guenter; Harbron, Chris; Mundt, Kirsten; Wassner-Fritsch, Elisabeth; Cheson, Bruce D. Share Save
Embracing model-based designs for dose-finding trials Love, Sharon B.; Brown, Sarah; Weir, Christopher J.; Harbron, Chris; Yap, Christina; Gaschler-Markefski, Birgit; Matcham, James; Caffrey, Louise; McKevitt, Christopher; Clive, Sally; Craddock, Charlie; Spicer, James; Cornelius, Victoria Share Save
Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples Veldman-Jones, Margaret H.; Brant, Roz; Rooney, Claire; Geh, Catherine; Emery, Hollie; Harbron, Chris G.; Wappett, Mark; Sharpe, Alan; Dymond, Michael; Barrett, J. Carl; Harrington, Elizabeth A.; Marshall, Gayle Share Save
Share Save
Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinic Hodgson, D.; Mason, H.; Oplustilova, L.; Harbron, C.; Yin, X.; Im, S. A.; Jones, H.; Zhongwu, L.; Dougherty, B.; McLoughlin, M.; Dickinson, A.; Fielding, A.; Robertson, J.; Kim, W. H.; Womack, C.; Gu, Y.; Bang, Y. J.; Lau, A.; Barrett, J. C.; O'Connor, M. J. Share Save
Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinic Hodgson, Darren; Mason, Helen; Oplustilova, Lenka; Harbron, Chris; Yin, Xiaolu; Im, Seock-Ah; Jones, Helen; Lai Zhongwu; Dougherty, Brian; McLoughlin, Matthew; Bradford, James; Dickinson, Andrew; Fielding, Anitra; Robertson, Jane; Kim, Woo-Ho; Womack, Chris; Gu, Yi; Bang, Yung-Jue; Lau, Alan; Barrett, J. Carl; O'Connor, Mark J. Share Save
Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours (vol 462, pg 269, 2013) Milner, Roy; Wombwell, Helen; Eckersley, Sonia; Barnes, Donna; Warwicker, Juli; Van Dorp, Erica; Rowlinson, Rachel; Dearden, Simon; Hughes, Glen; Harbron, Chris; Wellings, Bob; Hodgson, Darren; Womack, Chris; Gray, Neil; Lau, Alan; O'Connor, Mark J.; Marsden, Catherine; Kvist, Alexander J. Share Save
Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours Milner, Roy; Wombwell, Helen; Eckersley, Sonia; Barnes, Donna; Warwicker, Juli; Van Dorp, Erica; Dearden, Simon; Hughes, Glen; Harbron, Chris; Wellings, Bob; Hodgson, Darren; Womack, Chris; Gray, Neil; Lau, Alan; O'Connor, Mark J.; Marsden, Catherine; Kvist, Alexander J. Share Save
Share Save
Share Save
Exploring ATM deficiency as a potential therapeutic target for the PARP inhibitor olaparib in head and neck squamous cell carcinoma Senra, Joana M.; Donald, Emma L.; Williams, Victoria S.; Wombwell, Helen; Hall, Gillian; Harbron, Chris G.; Telfer, Brian A.; Morten, John; Womack, Chris; West, Catharine M.; Hodgson, Darren; O'Connor, Mark J.; Wedge, Steve R.; Strafford, Ian J. Share Save
Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) Dry, Jonathan R.; Pavey, Sandra; Pratilas, Christine A.; Harbron, Chris; Runswick, Sarah; Hodgson, Darren; Chresta, Christine; McCormack, Rose; Byrne, Natalie; Cockerill, Mark; Graham, Alexander; Beran, Garry; Cassidy, Andrew; Haggerty, Carolyn; Brown, Helen; Ellison, Gillian; Dering, Judy; Taylor, Barry S.; Stark, Mitchell; Bonazzi, Vanessa; Ravishankar, Sugandha; Packer, Leisl; Xing, Feng; Solit, David B.; Finn, Richard S.; Rosen, Neal; Hayward, Nicholas K.; French, Tim; Smith, Paul D. Share Save
Identification of gene expression biomarkers that predict sensitivity to the PARP inhibitor olaparib Lau, Alan; Dry, Jonathan; Harbron, Chris; Knights, Charlotte; Riches, Lucy; Mangena, Ramu; Avis, Tim; Brown, Helen; Runswick, Sarah; Dearden, Simon; O'Shaughnessy, Aisling; Unwin, Louise; Prime, John E.; Hodgson, Darren; Carmichael, James; O'Connor, Mark J. Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}